簡介

本頁面提供了有關 Jay S Skyler 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Jay S Skyler已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:APLT / Applied Therapeutics, Inc. Director 0
US:DXCM / DexCom, Inc. Director 63,348
US:AMLN / Amylin Pharmaceuticals Inc Director 0
如何解讀這些圖表

以下圖表顯示了在Jay S Skyler進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Jay S Skyler 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-02-03 2026-02-03 4 APLT Applied Therapeutics, Inc.
Common Stock
U - Other -42,500 0 -100.00
2026-02-03 2026-02-03 4 APLT Applied Therapeutics, Inc.
Common Stock
D - Sale to Issuer -22,500 42,500 -34.62
2024-06-07 2024-06-06 4 APLT Applied Therapeutics, Inc.
Common Stock
A - Award 45,000 65,000 225.00
2023-06-08 2023-06-06 4 APLT Applied Therapeutics Inc.
Common Stock
A - Award 20,000 20,000
2023-05-22 2023-05-18 4 DXCM DEXCOM INC
Common Stock
G - Gift 3,876 63,348 6.52
2023-05-22 2023-05-18 4 DXCM DEXCOM INC
Common Stock
G - Gift -3,876 0 -100.00
2022-05-23 2022-05-20 4 DXCM DEXCOM INC
Common Stock
A - Award 969 969 0.00 1 1
2022-05-23 2022-05-19 4 DXCM DEXCOM INC
Common Stock
J - Other 900 14,868 6.44
2022-05-23 2022-05-19 4 DXCM DEXCOM INC
Common Stock
J - Other -900 0 -100.00
2021-06-24 2021-06-22 4 DXCM DEXCOM INC
Common Stock
S - Sale X -5,402 13,968 -27.89 427.14 -2,307,409 5,966,287
2021-06-24 2021-06-22 4 DXCM DEXCOM INC
Common Stock
S - Sale X -8,334 19,370 -30.08 426.56 -3,554,967 8,262,504
2021-06-24 2021-06-22 4 DXCM DEXCOM INC
Common Stock
S - Sale X -6,264 27,704 -18.44 425.45 -2,665,031 11,786,719
2021-06-04 2021-06-03 4 APLT Applied Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 16,500 16,500
2021-05-25 2021-05-21 4 DXCM DEXCOM INC
Common Stock
A - Award 900 900 0.00 1 1
2021-05-25 2021-05-20 4 DXCM DEXCOM INC
Common Stock
J - Other 822 33,968 2.48
2021-05-25 2021-05-20 4 DXCM DEXCOM INC
Common Stock
J - Other -822 0 -100.00
2020-06-05 2020-06-04 4 APLT Applied Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 10,230 10,230
2020-05-27 2020-05-22 4 DXCM DEXCOM INC
Common Stock
A - Award 822 822 0.00 1 1
2020-05-27 2020-05-21 4 DXCM DEXCOM INC
Common Stock
J - Other 2,729 33,146 8.97
2020-05-27 2020-05-21 4 DXCM DEXCOM INC
Common Stock
J - Other -2,729 0 -100.00
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -3,086 30,417 -9.21 218.94 -675,635 6,659,364
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -14,456 33,503 -30.14 218.14 -3,153,417 7,308,311
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -5,564 47,959 -10.40 217.31 -1,209,127 10,422,095
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -2,700 53,523 -4.80 216.16 -583,636 11,569,612
2019-06-04 2019-05-31 4 DXCM DEXCOM INC
Common Stock
A - Award 2,729 2,729 0.00 3 3
2019-06-04 2019-05-30 4 DXCM DEXCOM INC
Common Stock
J - Other 3,607 56,223 6.86
2019-06-04 2019-05-30 4 DXCM DEXCOM INC
Common Stock
J - Other -3,607 0 -100.00
2019-05-15 2019-05-13 4 APLT Applied Therapeutics Inc.
Stock Option (right to buy)
A - Award 20,460 20,460
2019-02-15 2018-06-01 5 DXCM DEXCOM INC
Common Stock
J - Other 4,553 26,810 20.46
2019-02-15 2018-06-01 5 DXCM DEXCOM INC
Common Stock
J - Other -4,553 3,607 -55.80
2019-01-04 2019-01-02 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -25,806 0 -100.00
2019-01-04 2019-01-02 4 DXCM DEXCOM INC
Common Stock
M - Exercise 25,806 52,616 96.26 4.58 118,191 240,981
2018-06-26 2018-06-01 4/A DXCM DEXCOM INC
Common Stock
A - Award 3,607 3,607 0.00 4 4
2018-06-04 2018-05-31 4 DXCM DEXCOM INC
Common Stock
A - Award 3,616 8,169 79.42 0.00 4 8
2018-05-16 2018-05-14 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -30,000 25,806 -53.76
2018-05-16 2018-05-14 4 DXCM DEXCOM INC
Common Stock
S - Sale -30,000 22,257 -57.41 88.00 -2,640,000 1,958,616
2018-05-16 2018-05-14 4 DXCM DEXCOM INC
Common Stock
M - Exercise 30,000 52,257 134.79 4.58 137,400 239,337
2018-05-09 2018-05-08 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -31,464 0 -100.00
2018-05-09 2018-05-08 4 DXCM DEXCOM INC
Common Stock
S - Sale -31,464 22,257 -58.57 85.11 -2,678,024 1,894,380
2018-05-09 2018-05-08 4 DXCM DEXCOM INC
Common Stock
M - Exercise 31,464 53,721 141.37 7.63 240,070 409,891
2017-06-05 2017-06-01 4 DXCM DEXCOM INC
Common Stock
A - Award 4,553 4,553 0.00 5 5
2017-03-08 2017-03-06 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -31,890 0 -100.00 78.13 -2,491,572
2017-03-08 2017-03-06 4 DXCM DEXCOM INC
Common Stock
S - Sale -31,890 17,246 -64.90 78.13 -2,491,572 1,347,433
2017-03-08 2017-03-06 4 DXCM DEXCOM INC
Common Stock
M - Exercise 31,890 49,136 184.91 7.31 233,116 359,184
2016-09-14 2016-09-12 4 DXCM DEXCOM INC
Common Stock
S - Sale -10,000 0 -100.00 93.00 -930,000
2016-09-13 2016-09-09 4 DXCM DEXCOM INC
Common Stock
S - Sale -25,000 17,246 -59.18 94.07 -2,351,788 1,622,357
2016-08-22 2016-08-19 4 DXCM DEXCOM INC
Common Stock
S - Sale -25,000 42,246 -37.18 90.77 -2,269,232 3,834,640
2016-05-26 2016-05-25 4 DXCM DEXCOM INC
Common Stock
A - Award 5,011 9,486 111.98 0.00 5 9
2015-08-19 2015-08-17 4 DXCM DEXCOM INC
Common Stock
S - Sale X -20,000 62,771 -24.16 96.65 -1,932,982 6,066,761
2015-07-17 2015-07-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -20,000 82,771 -19.46 81.69 -1,633,886 6,761,919
2015-06-16 2015-06-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -20,000 102,771 -16.29 70.67 -1,413,426 7,262,960
2015-06-05 2015-06-03 4 DXCM DEXCOM INC
Common Stock
A - Award 4,475 4,475 0.00 4 4
2015-03-13 2015-03-13 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 0 -100.00 60.01 -600,142
2015-03-13 2015-03-13 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -6,500 0 -100.00 60.01 -390,092
2015-03-13 2015-03-13 4 DXCM DEXCOM INC
Common Stock
S - Sale -10,000 115,884 -7.94 60.01 -600,142 6,954,686
2015-03-13 2015-03-13 4 DXCM DEXCOM INC
Common Stock
M - Exercise 10,000 125,884 8.63 21.81 218,100 2,745,530
2015-03-13 2015-03-13 4 DXCM DEXCOM INC
Common Stock
S - Sale -6,500 115,884 -5.31 60.01 -390,092 6,954,686
2015-03-13 2015-03-13 4 DXCM DEXCOM INC
Common Stock
M - Exercise 6,500 122,384 5.61 20.38 132,470 2,494,186
2015-03-13 2015-03-12 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3,500 6,500 -35.00 60.00 -210,000 390,000
2015-03-13 2015-03-12 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3,436 0 -100.00 60.00 -206,160
2015-03-13 2015-03-12 4 DXCM DEXCOM INC
Common Stock
S - Sale -3,500 115,884 -2.93 60.00 -210,000 6,953,040
2015-03-13 2015-03-12 4 DXCM DEXCOM INC
Common Stock
M - Exercise 3,500 119,384 3.02 20.38 71,330 2,433,046
2015-03-13 2015-03-12 4 DXCM DEXCOM INC
Common Stock
S - Sale -3,436 115,884 -2.88 60.00 -206,160 6,953,040
2015-03-13 2015-03-12 4 DXCM DEXCOM INC
Common Stock
M - Exercise 3,436 119,320 2.97 12.00 41,232 1,431,840
2015-03-13 2015-03-11 4 DXCM DEXCOM INC
Non-Qualified Stock Option (right to buy)
M - Exercise -21,564 3,436 -86.26 60.00 -1,293,903 206,170
2015-03-13 2015-03-11 4 DXCM DEXCOM INC
Common Stock
S - Sale -21,564 115,884 -15.69 60.00 -1,293,903 6,953,376
2015-03-13 2015-03-11 4 DXCM DEXCOM INC
Common Stock
M - Exercise 21,564 137,448 18.61 12.00 258,768 1,649,376
2014-07-03 2014-07-02 4 DXCM DEXCOM INC
Common Stock
S - Sale X -12,200 115,884 -9.52 40.09 -489,115 4,645,952
2014-07-03 2014-07-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -17,800 128,084 -12.20 40.02 -712,290 5,125,448
2014-06-23 2014-06-20 4 DXCM DEXCOM INC
Common Stock
S - Sale X -30,000 145,884 -17.06 40.00 -1,200,000 5,835,360
2014-06-23 2014-06-19 4 DXCM DEXCOM INC
Common Stock
S - Sale X -30,000 175,884 -14.57 40.00 -1,200,000 7,035,360
2014-06-03 2014-05-30 4 DXCM DEXCOM INC
Common Stock
A - Award 6,887 6,887 0.00 7 7
2014-04-03 2014-04-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -30,000 205,884 -12.72 41.29 -1,238,799 8,501,630
2014-03-28 2014-03-26 4 DXCM DEXCOM INC
Common Stock
S - Sale X -30,000 235,884 -11.28 43.05 -1,291,458 10,154,476
2013-06-04 2013-05-31 4 DXCM DEXCOM INC
Common Stock
A - Award 11,848 133,823 9.71 0.00 12 134
2013-03-11 2013-03-11 4 DXCM DEXCOM INC
Common Stock
P - Purchase 70,000 121,975 134.68 15.50 1,085,000 1,890,612
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Phantom Stock-Deferred Compensation
J - Other -7,039 0 -100.00 31.00 -218,209
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Phantom Stock Units
J - Other -7,021 0 -100.00 31.00 -217,651
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
H - Other -12,000 0 -100.00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
H - Other -12,000 0 -100.00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
H - Other -12,000 0 -100.00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -20,000 0 -100.00 31.00 -620,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -20,000 0 -100.00 31.00 -620,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -12,000 0 -100.00 31.00 -372,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -12,000 0 -100.00 31.00 -372,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -20,000 0 -100.00 31.00 -620,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -12,000 0 -100.00 31.00 -372,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -20,000 0 -100.00 31.00 -620,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other -20,000 0 -100.00 31.00 -620,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other -6,675 0 -100.00 31.00 -206,925
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other -201 0 -100.00 31.00 -6,231
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other -23,000 0 -100.00 31.00 -713,000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other -98,286 0 -100.00 31.00 -3,046,866
2012-06-05 2012-06-01 4 DXCM DEXCOM INC
Common Stock
A - Award 19,153 51,975 58.35 0.00 19 52
2012-05-17 2012-05-15 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 20,000 20,000
2012-05-17 2012-05-15 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 3,000 98,286 3.15
2012-05-14 2012-05-11 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2012-05-14 2012-05-11 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8,000 0 -100.00
2012-05-14 2012-05-11 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
M - Exercise 8,000 95,286 9.17 9.16 73,280 872,820
2012-05-14 2012-05-11 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 87,286 12.94 9.40 94,000 820,488
2008-01-14 2008-01-10 4 AMLN AMYLIN PHARMACEUTICALS INC
Phantom Stock-Deferred Compensation
A - Award 407 5,290 8.34 35.25 14,347 186,472
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)